The share price of Zoetic International (LON: ZOE) surged by over ten percent today as news that it was making a stronger play for US investors was well received by the markets.
CBC business ZOE announced that it had begun trading on the OTCQX Best Market in the U.S., under the ticker symbol ZOEIF in addition to its current listing on AIM.
Perhaps more telling was the fact that it is making a more strategic play to attract US investors – noting it is evaluating opportunities to improve investor relations in North America. It added that US investors will have an opportunity to buy into a company with high quality CBD products internationally, disrupting the tobacco industry.
Following this news as well as confirmation in the MSCI Microcap Index, the ZOE share price reached as a high as 76p during intraday trading.
Commenting on the performance to date as well as multi-year growth plans was Trevor Taylor, Co-CEO of ZOE:
“The combination of trading on OTCQX and index inclusion reflect the Company’s tremendous progress towards transitioning to a pure play, integrated CBD company over the past 12 months. Our recent product development and wholesale distribution expansion have set the stage for the first leg of projected multi-year, sustainable growth for the Company. We couldn’t be more pleased with our progress to date, as well as our current position in this high-growth market.”